Dyserythropoiesis in 105 patients with visceral leishmaniasis

Laboratory Hematology

Volumn 10, Issue 4, 2004, Pages 206-211

  Sheikha, Anwar ^a,b  

^a KING KHALID UNIVERSITY   (Saudi Arabia)

^b NONE   (United States)

Author keywords

Congenital dyserythropoietic anemia; Dyserythropoiesis; Kala azar; Leishman Donovan bodies; Visceral leishmaniasis

Indexed keywords

CHEMOKINE; CYTOKINE;

ARTICLE; BONE MARROW EXAMINATION; CELL NUCLEUS; CLINICAL FEATURE; CONGENITAL DYSERYTHROPOIETIC ANEMIA; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; DISEASE SEVERITY; DYSERYTHROPOIESIS; HOSPITAL DEPARTMENT; HUMAN; HUMAN TISSUE; LEISHMANIA DONOVANI; MAJOR CLINICAL STUDY; MICROSCOPY; NONHUMAN; PARASITE IDENTIFICATION; PARASITEMIA; PATHOGENESIS; VISCERAL LEISHMANIASIS;

EID: 11244296251     PISSN: 10802924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Lewis SM, Verwilghen RL. Dyserythropoiesis and dyserythropoietic anemias. Prog Hematol. 1973;8:99-129.
2. Lewis SM, Verwilghen RL, eds. Dyserythropoiesis. London, UK: Academic Press; 1977.
3. Heimpel H, Wendt F. Congenital dyserythropoietic anemia with karyorrhexis and multinuclearity of erythroblasts. Helv Med Acta. 1968;34:103-115.
4. Wickramasinghe SN. Dyserythropoiesis and congenital dyserythropoietic anaemia. Br J Haematol. 1997;98:785-797.
5. Wickramasinghe SN. Congenital dyserythropoietic anaemias: clinical features, haematological morphology and new biochemical data. Blood Rev. 1998;12:178-200.
6. Iolascon A, D'Agostaro G, Perrotta S, Izzo P, Miraglia del Giudice E. Congenital dyserythropoietic anemia type II: molecular basis and clinical aspects. Haematologica. 1996;81:543-559.
7. Heimpel H, Anselstetter V, Chrobak L, et al. Congenital dyserythropoietic anemia type II: epidemiology, clinical appearance, and prognosis based on long-term observation. Blood. 2003;102:4576-4581.
8. Iolascon A, Delaunay J, Wickramasinghe S, Perrotta S, Gigante M, Camaschella. Natural history of congenital dyserythropoietic anemia type II. Blood. 2001;98:1258-1260.
9. Delaunay J, Iolascon A. The congenital dyserythropoietic anemias. Bailleres Best Pract Res Clin Haematol. 1999;12:691-705.
10. World Health Organization. Control of the Leishmaniasis. Report of a WHO Expert Committee. Geneva, Switzerland: World Health Organization; 1990. World Health Organization Technical Report Series no. 793:155.
11. Murray, HW. Kala-azar: progress against a neglected disease. N Engl J Med. 2002;347:1793-1794.
12. Sundar S, Jha TK, Thakur CP, et al. Oral miltefosine for Indian visceral leishmaniasis. N Engl J Med. 2002;347:1739-1746.
13. Guerin PJ, Olliaro P, Sundar S, et al. Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect Dis. 2002;2:494-501.
14. Sundar S, Sahu M, Mehta H, et al. Noninvasive management of Indian visceral leishmaniasis: clinical application of diagnosis by K39 antigen strip testing at a kala-azar referral unit. Clin Infect Dis. 2002;35:581-586.
15. Duvogiannis M, Argitakos T, Tsoukali E, Boukas C, Tzilanos M. Visceral leishmaniasis (kala-azar): epidemiology, clinical features, laboratory findings and prognosis [review of 15 cases]. Br J Haematol. 1998;102(1-I):95.
16. Salotra P, Sreenivas G, Pogue GP, et al. Development of a species-specific PCR assay for detection of Leishmania donovani in clinical samples from patients with kala-azar and post-kala-azar leishmaniasis. J Clin Microbiol. 2001;39:849-854.
17. Spanakos G, Patsoula E, Kremastinou T, Saroglou G, Vakalis N. Development of a PCR-based method for diagnosis of leishmania in blood samples. Mol Cell Probes. 2002;16:415-420.
18. Sheikha A, Al-Janadi M, Malik J, et al. Visceral leishmaniasis with a very low degree of bone marrow parasitemia, mimicking malignant histiocytosis. Int J Oncol. 1993;3:477-480.
19. Matzner Y, Behar A, Beeri E, et al. Systemic leishmaniasis mimicking malignant histiocytosis. Cancer. 1979;43:398-402.
20. al-Jurayyan NA, al-Nasser MN, al-Fawaz IM, et al. The haematological manifestations of visceral leishmaniasis in infancy and childhood. J Trop Pediatr. 1995;41:143-148.
21. Singh K, Singh R, Parija SC, Faridi MM, Bhatta N. Clinical and laboratory study of kala-azar in children in Nepal. J Trop Pediatr. 1999;45:95-97.
22. Kager PA, Rees PH. Haematological investigations in visceral leishmaniasis. Trop Geogr Med. 1986;38:371-379.
23. Knezevic K, Turkulov V, Celanovic M. Leishmaniasis: case report [in Croatian]. Med Pregl. 1998;51:551-553.
24. Mehabresh MI, el-Mauhoub MM. Visceral leishmaniasis in Libya: review of 21 cases. Ann Trop Paediatr. 1992;12: 159-163.
25. Bruckner DA, Labarca JA. Leishmania and trypanosoma. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of Clinical Microbiology. Washington, DC: ASM Press; 1999:1365-1373.
26. Mukherjee C, Mitra PK, Dasgupta A, Ghosh RN. Clinicopathological study of clinically undiagnosed cases of kala-azar with special reference to grading of parasites. J Indian Med Assoc. 1995;93:87-89.
27. World Health Organization. Leishmania/HIV Co-Infection in Southwestern Europe 1990-98: Retrospective Analysis of 965 Cases. Geneva, Switzerland: World Health Organization; 2000. Publication WHO/LEISH/2000/42.
28. Crookston JH, Crookston MC, Burnie KL, et al. Hereditary erythroblastic multinuclearity associated with a positive acidified-serum test: a type of congenital dyserythropoietic anaemia. Br J Haematol. 1969;17:11-26.
29. Murray HW. Clinical and experimental advances in treatment of visceral leishmaniasis. Antimicrob Agents Chemother. 2001;45: 2185-2197.
30. Pippard MJ, Moir D, Weatherall DJ, Lenicker HM. Mechanism of anemia in resistant visceral leishmaniasis. Ann Trop Parasitol. 1986;80:317-323.
31. Wickramasinghe SN, Abdalla SH, Kasili EG. Ultrastructure of bone marrow in patients with visceral leishmaniasis. J Clin Pathol. 1987;40:267-275.
32. Olivieri O, Gandini G, Baiocco R, Aprili G, Falezza G, De Sandre G. Visceral leishmaniasis presenting as dyserythropoiesis associated with increased i-antigenicity of erythrocytes. Haematologica. 1987;72:163-165.
33. Shahriar D, Reza MP, Reza AM, Faramarz S. Cytological clues of bone marrow findings in Kala-Azar. Diagn Cytopathol. 1999;20:208-211.